News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
63,511 Results
Type
Article (3791)
Company Profile (5)
Press Release (59715)
Section
Business (28878)
Career Advice (136)
Deals (4375)
Drug Delivery (2)
Drug Development (7554)
Employer Resources (5)
FDA (1286)
Job Trends (1995)
News (40388)
Policy (2383)
Tag
Academia (112)
Accelerated approval (1)
Adcomms (1)
Allergies (3)
Alliances (2737)
ALS (3)
Alzheimer's disease (108)
Antibody-drug conjugate (ADC) (4)
Approvals (1317)
Artificial intelligence (11)
Autoimmune disease (2)
Bankruptcy (27)
Best Places to Work (1469)
BIOSECURE Act (4)
Biosimilars (13)
Biotechnology (5)
Bladder cancer (21)
Brain cancer (1)
Breast cancer (45)
Cancer (260)
Cardiovascular disease (21)
Career advice (132)
CAR-T (9)
Cell therapy (24)
Cervical cancer (5)
Clinical research (6653)
Collaboration (48)
Compensation (24)
Complete response letters (1)
COVID-19 (156)
CRISPR (7)
C-suite (11)
Cystic fibrosis (6)
Data (325)
Depression (4)
Diabetes (17)
Diagnostics (631)
Digital health (2)
Diversity, equity & inclusion (1)
Drug discovery (5)
Drug pricing (4)
Duchenne muscular dystrophy (9)
Earnings (24351)
Editorial (2)
Employer branding (3)
Employer resources (4)
Events (7859)
Executive appointments (25)
FDA (1490)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (36)
Gene editing (10)
Generative AI (1)
Gene therapy (19)
GLP-1 (73)
Government (233)
Guidances (86)
Healthcare (2063)
IgA nephropathy (5)
Immunology and inflammation (7)
Indications (3)
Infectious disease (163)
Inflammatory bowel disease (12)
Influenza (3)
Intellectual property (7)
Interviews (12)
IPO (2995)
Job creations (607)
Job search strategy (130)
Kidney cancer (4)
Labor market (2)
Layoffs (55)
Legal (511)
Liver cancer (3)
Lung cancer (36)
Lymphoma (27)
Manufacturing (16)
MASH (13)
Medical device (1458)
Medtech (1458)
Mergers & acquisitions (1405)
Metabolic disorders (55)
Multiple sclerosis (12)
NASH (3)
Neurodegenerative disease (3)
Neuropsychiatric disorders (1)
Neuroscience (149)
NextGen: Class of 2025 (693)
Non-profit (253)
Obesity (22)
Opinion (13)
Ovarian cancer (11)
Pain (9)
Pancreatic cancer (8)
Parkinson's disease (11)
Partnered (2)
Patents (19)
Patient recruitment (7)
Peanut (1)
People (2187)
Pharmaceutical (1)
Pharmacy benefit managers (2)
Phase I (1631)
Phase II (2637)
Phase III (2999)
Pipeline (496)
Policy (6)
Postmarket research (257)
Preclinical (495)
Press Release (2)
Prostate cancer (7)
Psychedelics (1)
Radiopharmaceuticals (26)
Rare diseases (33)
Real estate (405)
Recruiting (3)
Regulatory (1814)
Reports (7)
Research institute (132)
Resumes & cover letters (8)
Rett syndrome (1)
RSV (2)
Schizophrenia (9)
Series A (4)
Series B (1)
Sickle cell disease (3)
Special edition (1)
Spinal muscular atrophy (22)
Startups (247)
Stomach cancer (2)
Tariffs (2)
Vaccines (59)
Venture capitalists (1)
Weight loss (12)
Women's health (1)
Date
Last 7 days (215)
Last 30 days (425)
Last 365 days (4265)
2025 (1588)
2024 (4678)
2023 (5229)
2022 (6549)
2021 (6328)
2020 (5318)
2019 (4328)
2018 (3448)
2017 (4330)
2016 (3089)
2015 (2802)
2014 (1915)
2013 (1191)
2012 (1535)
2011 (1647)
2010 (1508)
Location
Africa (130)
Alabama (5)
Alaska (1)
Arizona (14)
Asia (4971)
Australia (504)
California (741)
Canada (216)
China (46)
Colorado (51)
Connecticut (44)
Delaware (32)
Europe (9403)
Florida (133)
Georgia (27)
Idaho (4)
Illinois (73)
India (3)
Indiana (47)
Japan (61)
Kansas (14)
Kentucky (1)
Louisiana (4)
Maine (14)
Maryland (88)
Massachusetts (589)
Michigan (29)
Minnesota (46)
Missouri (5)
Montana (2)
Nebraska (2)
Nevada (11)
New Hampshire (8)
New Jersey (351)
New Mexico (1)
New York (237)
North Carolina (116)
Northern California (351)
Ohio (15)
Pennsylvania (166)
Puerto Rico (2)
South America (162)
South Carolina (1)
Southern California (301)
Tennessee (6)
Texas (88)
United States (2973)
Utah (32)
Virginia (6)
Washington D.C. (2)
Washington State (55)
Wisconsin (4)
63,511 Results for "81".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oncology Market Size to Surpass USD 903.81 Billion by 2034
February 28, 2025
·
1 min read
Press Releases
Cell Expansion Market Size to Exceed USD 61.81 Billion by 2034
February 26, 2025
·
1 min read
Press Releases
Biobanking Market Size Projected to Surge to US$ 208.81 Billion by 2034
February 18, 2025
·
1 min read
Press Releases
Proteomics Market to Reach USD 95.81 Billion to 2034 - Exclusive Report by Nova one advisor
February 7, 2025
·
1 min read
Press Releases
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
March 6, 2025
·
13 min read
Pharm Country
Elion Therapeutics Closes $81 Million Series B Funding Round Led by Deerfield Management and AMR Action Fund
Elion Therapeutics announced today it has closed a $81 million Series B funding round led by Deerfield Management (“Deerfield”) and the AMR Action Fund. Additional investors include Illinois Ventures.
June 17, 2024
·
4 min read
Pharmaceutical Excipients Market Size USD 14.72 Billion by 2033 and CAGR 5.81%
The global pharmaceutical excipients market size was accounted for USD 8.37 billion in 2023 and it is projected to increase over USD 14.72 billion by 2033 with a CAGR of 5.81% from 2024 to 2033.
May 9, 2024
·
9 min read
Biotech Bay
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
XOMA Corporation, the biotech royalty aggregator, announced it has received an $8.1 million milestone payment from Viracta Therapeutics, Inc., related to Day One Biopharmaceuticals’ recent sale of its Priority Review Voucher for $108 million to an undisclosed buyer.
June 12, 2024
·
4 min read
VC Financings Drop 20% in Q1 but Megarounds Keep Median Deal Size High
Biopharma venture capital fundraising declined from $8.1 billion in the first quarter of 2024 to $6.5 billion in the first three months of this year, headlined by a clutch of massive funding rounds.
May 6, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Intravenous Immunoglobulin Market Experiencing Growth of 8.1% by 2034
October 8, 2024
·
1 min read
1 of 6,352
Next
